Aflibercept in diabetic macular oedema: Added benefit not proven
Monday, December 15, 2014 - 17:00
in Health & Medicine
There were no relevant differences between the treatment groups for patients in whom the area of greatest visual acuity is also affected. For other patients, data were lacking.